<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03902704</url>
  </required_header>
  <id_info>
    <org_study_id>Rov-Clever-2017</org_study_id>
    <nct_id>NCT03902704</nct_id>
  </id_info>
  <brief_title>Safety and Efficacy of Cleverscope. A New Medical Device for Tracheal Intubation</brief_title>
  <official_title>Safety and Efficacy Assessment of a New Tracheal Intubation Device Cleverscope. Success Rate of Cleverscope in Patients With Suspected Difficult Airway.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Hospital General Universitario de Valencia</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>FIPSE</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Hospital General Universitario de Valencia</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Cleverscope is a new medical device that transform a laryngoscope into a videolaryngoscope.
      previous its commercialization we evaluate its safety and efficacy.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      the investigators develope two part study. part I: the investigators collect data of 50
      patients prospectively programed for general anesthesia and tracheal intubation without
      predictors of difficult airways. this patients were intubated with cleverscope, the
      investigators register best cormack-lehane (glottic vision) obtained with Cleverscope and
      best cormack obtained with direct laryngoscopy. the investigators register intubation succes
      rate and any complications during its use and after extubation.

      part II: after confirm safety and efficacy in patients without difficult airways (part I) the
      investigators use Cleverscope for the same pourpose on difficult airways patients. collecting
      same data . the investigators compare cormack-lehane in this patients with Cleverscope and
      commercial Videolaryngoscope C-MAC.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">October 1, 2017</start_date>
  <completion_date type="Anticipated">October 1, 2020</completion_date>
  <primary_completion_date type="Anticipated">October 1, 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <intervention_model_description>part 1 its single group of participants(50 patients without difficult airways predictors). this group receives direct laringoscopy with common laryngoscope (L) during the initial phase of the trial, followed by videolaryngoscope (VL) Cleverscope (used for intubation) during a later phase.
part 2 of the study its two-by-two cross-over assignment involves two groups of participants(84 patients with difficult airways predictors). One group receives VL with C-MAC during the initial phase of the trial, followed by Cleverscope for intubation during a later phase. The other group receives VL with Cleverscope during the initial phase, followed by C-MAC VL used for intubation. So during the part 2 trial, participants &quot;cross over&quot; to the other videolaringoscopy.</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Cormack-Lehane Glotic visualization scale (I(complete view, easy to intubate)-IV(no view, imposible to intubate)</measure>
    <time_frame>intraoperative</time_frame>
    <description>degree of glotis visualization</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>First attempt intubation success rate</measure>
    <time_frame>intraoperative</time_frame>
    <description>the rate of traqueal tube pass through vocal cords at first attemps.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>overall success intubation rate with same device</measure>
    <time_frame>intraoperative</time_frame>
    <description>it could include more attempts</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>time to success</measure>
    <time_frame>intraoperative</time_frame>
    <description>time wasted from device inserted into mouth to inflate tracheal tube</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>complications rate</measure>
    <time_frame>intraoperative</time_frame>
    <description>register complications during intubation or due device usage. like hemorrage, mucosal laceration,</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">134</enrollment>
  <condition>Anesthesia Intubation Complication</condition>
  <condition>Difficult Intubation</condition>
  <arm_group>
    <arm_group_label>Cleverscope</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Cleverscope is a new videolaryngoscope used for tracheal intubation. in this group we use this device to intubate participants.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Laryngoscope / Videolaryngoscope C-MAC® Storz</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>in this group we use a standart comercial device for intubation (laryngoscope or C-MAC) to intubate participants</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Cleverscope</intervention_name>
    <description>the device is used in patients without difficult airways predictors</description>
    <arm_group_label>Cleverscope</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Laryngoscope / Videolaryngoscope C-MAC® Storz</intervention_name>
    <description>the device is used in patients with difficult airways predictors</description>
    <arm_group_label>Laryngoscope / Videolaryngoscope C-MAC® Storz</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  part 1: Scheduled Patients for any kind of surgery with general anesthesia with
             tracheal intubation without predictors of difficult intubation :

               1. Arne Test &lt; 10

               2. cervical circunference / tyromental distance &lt; 4.

          -  part 2: Scheduled Patients for any kind of surgery with general anesthesia with
             tracheal intubation with predictors of difficult intubation :

               1. Arne Test &gt; 10

               2. cervical circunference / tyromental distance &gt; 4.

        Exclusion Criteria:

          -  no mouth openning &gt;2cm

          -  required use of awake fiberscope por tracheal intubation
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Lucas Rovira, PhD</last_name>
    <phone>+34659276476</phone>
    <email>lucasrovira@gmail.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Lucas Rovira</name>
      <address>
        <city>La Pobla De Vallbona</city>
        <state>Valencia</state>
        <zip>46185</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Lucas Rovira, PhD</last_name>
      <phone>+34659276476</phone>
      <email>lucasrovira@gmail.com</email>
    </contact>
    <investigator>
      <last_name>Lucas Rovira, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Spain</country>
  </location_countries>
  <verification_date>June 2019</verification_date>
  <study_first_submitted>March 31, 2019</study_first_submitted>
  <study_first_submitted_qc>April 3, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">April 4, 2019</study_first_posted>
  <last_update_submitted>June 5, 2019</last_update_submitted>
  <last_update_submitted_qc>June 5, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">June 7, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Hospital General Universitario de Valencia</investigator_affiliation>
    <investigator_full_name>Lucas Rovira</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <keyword>videolaryngoscopy</keyword>
  <keyword>tracheal intubation</keyword>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

